PRKACA and neoplasm: The results showed that in the GC cohort, high PRKACA expression was significantly associated with the 60-years-and-below age group, higher nodal stage, and late disease stage but not with gender, histological tumor type, pathological tumor stage, or distant metastasis (Table 1).